Clinical Endpoints and Outcomes From COMET-2 and -3 in Dry Eye Disease | Optometry Times - Clinical News

Published on December 11, 2025
Continue reading on website
Other news

AMD Eyes Treated with L-dopa Linked to Reduced Conversion to Later Stages

December 11, 2025
Recent findings affirm the potential of L-dopa as a therapeutic in preventing progression to neovascular AMD. Photo: Carolyn Majcher, OD. Click image to enlarge. Levodopa (L-dopa), a precursor to dopamine in the melanin synthesis pathway and a mainstay of Parkinson’s disease therapy, has been proposed as a potential agent for delaying progression to advanced AMD, neovascular

Questionable testing waivers put KY's licensing of optometrists under scrutiny

December 11, 2025
Kentucky relaxed licensing standards for almost two dozen new optometrists, triggering alarm from a national optometry board and state lawmaker.